Referral to gastroenterology is appropriate when patients experience persistent symptoms despite conservative management, require objective gastroparesis diagnosis, or need specialized nutritional support
Promotes healthy skin and reduces signs of aging
obesity rate dropped from 39.9 percent in 2022 to 37 percent in 2025
In supplement manufacturing, the pair is most suitable for sports nutrition powders, capsules, tablets, and energy-drink premixes when moisture control, assay verification, and compliant structure/function claims are in place
To qualify for Wegovy, youll typically need one of the following: A BMI of 30 or higher (classified as obesity ), or A BMI of 27 or higher with at least one weight-related health condition Weight-related conditions may include: High blood pressure (hypertension) High cholesterol (dyslipidemia) Type 2 diabetes Heart disease Obstructive sleep apnea Polycystic ovary syndrome ( PCOS ) In addition, in March 2024 the FDA expanded Wegovys approval to include reducing the risk of major cardiovascular events like heart attac k, stroke, and cardiovascular death in adults with cardiovascular disease plus overweight or obesity
A provider should review your medical history, medications, symptoms, and lab work before recommending peptide therapy